Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-18T13:03:08.004Z Has data issue: false hasContentIssue false

Hypoplastic left heart in Turner’s syndrome: a primary indication for transplant?

Published online by Cambridge University Press:  13 December 2017

Joseph Philip*
Affiliation:
Congenital Heart Center, UF Health Shands Children’s Hospital, University of Florida, Gainesville, Florida, United States of America
Dipankar Gupta
Affiliation:
Congenital Heart Center, UF Health Shands Children’s Hospital, University of Florida, Gainesville, Florida, United States of America
Mark S. Bleiweis
Affiliation:
Congenital Heart Center, UF Health Shands Children’s Hospital, University of Florida, Gainesville, Florida, United States of America
Biagio A. Pietra
Affiliation:
Congenital Heart Center, UF Health Shands Children’s Hospital, University of Florida, Gainesville, Florida, United States of America
Himesh V. Vyas
Affiliation:
Congenital Heart Center, UF Health Shands Children’s Hospital, University of Florida, Gainesville, Florida, United States of America
*
Correspondence to: J. Philip, MD, Congenital Heart Center, UF Health Shands Children’s Hospital, University of Florida, 1600 SW Archer road, PO Box 100297 Gainesville, FL 32610, United States of America. Tel: +1 352 273 7770; Fax: +352 273 5927; E-mail: subijo9@ufl.edu

Abstract

Survival for hypoplastic left heart syndrome patients following the Norwood procedure is 71–90%. Mortality in patients with Turner’s syndrome and hypoplastic left heart syndrome after conventional palliation (Norwood operation) has been reported as high as 80%. This questions the approach of traditional staged palliation. Here, we report a patient with hypoplastic left heart syndrome and Turner’s syndrome bridged to orthotopic heart transplantation following a hybrid procedure.

Type
Brief Report
Copyright
© Cambridge University Press 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Patel, A, Hickey, E, Mavroudis, C, Jacobs, JP, Jacobs, ML, Backer, CL, Gevitz, M, Mavroudis, CD. Impact of noncardiac congenital and genetic abnormalities on outcomes in hypoplastic left heart syndrome. Ann Thorac Surg 2010; 89: 18051813; discussion 1813-4.CrossRefGoogle ScholarPubMed
2. Natowicz, M, Kelley, RI. Association of Turner syndrome with hypoplastic left-heart syndrome. Am J Dis Child 1987; 141: 218220.Google ScholarPubMed
3. Lara, DA, Ethen, MK, Canfield, MA, Nembhard, WN, Morris, SA. A population‐based analysis of mortality in patients with Turner syndrome and hypoplastic left heart syndrome using the Texas Birth Defects Registry. Congenit Heart Dis 2017; 12: 105112.CrossRefGoogle ScholarPubMed
4. Reis, PM, Punch, MR, Bove, EL, van de Ven, CJ. Outcome of infants with hypoplastic left heart and Turner syndromes. Obstet Gynecol 1999; 93: 532535.Google Scholar
5. Cramer, JW, Bartz, PJ, Simpson, PM, Zangwill, SD. The spectrum of congenital heart disease and outcomes after surgical repair among children with Turner syndrome: a single-center review. Pediatr Cardiol 2014; 35: 253260.Google Scholar
6. Loscalzo, ML, Van, PL, Ho, VB, Bakalov, VK, Rosing, DR, Malone, CA, Dietz, HC, Bondy, CA. Association between fetal lymphedema and congenital cardiovascular defects in Turner syndrome. Pediatrics 2005; 115: 732735.CrossRefGoogle ScholarPubMed